You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 256 No. 3, July 18, 1986 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Letters
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Association Between HTLV-III/ LAV Infection and Tuberculosis in Zaire

Jonathan Mann, MD, MPH; Dixie E. Snider, Jr, MD, MPH; Henry Francis, MD; Thomas C. Quinn, MD; Robert L. Colebunders, MD; Peter Piot, MD; James W. Curran, MD, MPH; Nzila Nzilambi, MD; Ngaly Bosenge, MD; Matiatudila Malonga, MD, MPH; Dikilu Kalunga, MD; Masaki Mu Nzingg, MD; Nkoko Bagala, MD

JAMA. 1986;256(3):346.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

To the Editor.—

Immunosuppression caused by drugs, infections, cancer, or other conditions is known to increase the risk of tuberculosis.1 Studies of patients with the acquired immunodeficiency syndrome (AIDS)2,3 and of the incidence of tuberculosis in young men in selected US cities4 suggest that an increased risk of overt disease among persons previously infected with the tubercle bacillus may be associated with human T-cell lymphotropic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV) infection.

Project SIDA is a collaborative AIDS research project in Zaire, involving the Zairian Department of Public Health, the Public Health Service, and the Institute of Tropical Medicine, Antwerp, Belgium. In March 1985, project researchers determined the prevalence of antibody to HTLV-III/LAV in 231 (84%) of the 274 inpatients of the tuberculosis sanatorium in Kinshasa, Zaire.

Of the 231 study participants, 159 (69% ) had confirmed pulmonary tuberculosis (positive results of sputum examination for acid-fast bacilli). Of these . . . [Full Text PDF of this Article]


Footnotes

Edited by Drummond Rennie, MD, Senior Contributing Editor; Sharon Iverson, Assistant Editor.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1986 American Medical Association. All Rights Reserved.